Soni Medicare Limited has scheduled a board meeting for Monday, October 26, 2026. The primary agenda is to consider and approve a proposal for entering into a Healthcare Operations and Management (O&M) Framework Agreement for Soni Hospital.

The company filed an intimation with BSE Limited pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The proposed agreement aims to engage a suitable vendor for the operations and management of Soni Hospital, which operates as a unit of the company.

Scope of the Proposed Agreement

The Board of Directors will evaluate the terms and conditions of the framework agreement. The decision involves selecting a suitable vendor to manage the healthcare facility's operations. This move suggests a potential shift towards outsourcing or specialized management for the hospital unit.

The agenda also includes the approval of ancillary matters, documents, and authorizations necessary to execute the proposal. The specific identity of the vendor and the financial terms of the contract were not disclosed in the initial filing.

Regulatory Compliance

The intimation was signed by Hari Krishan Tiwari, Company Secretary and Compliance Officer, on October 19, 2026. The company requested BSE to take the information on record for dissemination through its website.

Soni Medicare Limited reported a widening net loss and significant revenue contraction in its standalone financial results for the quarter ended June 30, 2026 (Q1FY27). The healthcare provider recorded a net loss of ₹119.85 lakh, compared to a net loss of ₹29.10 lakh in the same quarter last year. This deterioration coincided with a sharp decline in top-line growth, as revenue from operations fell 37.4% year-on-year to ₹455.27 lakh from ₹727.71 lakh in Q1FY26.

The financial performance reflects persistent pressure on margins, with total expenditure remaining elevated at ₹596.54 lakh despite the drop in revenue. Consequently, the company reported an EBITDA loss of ₹118.87 lakh for the quarter, expanding from an EBITDA loss of ₹29.35 lakh in the corresponding period of the previous fiscal year. Other income contributed ₹22.57 lakh to total revenue, which stood at ₹477.84 lakh.

Quarterly Financial Performance

In the preceding quarter (Q4FY26), Soni Medicare had reported a net loss of ₹36.63 lakh on revenue of ₹583.16 lakh. The current quarter’s results indicate a continued struggle to achieve operational profitability, with earnings per share (EPS) declining to -₹2.81 from -₹0.68 in the prior year.

What the Numbers Show

The divergence between revenue decline and expenditure levels highlights margin compression challenges. While revenue dropped by nearly 37%, total expenditure decreased by only 23.4% year-on-year. This mismatch resulted in the EBITDA loss more than quadrupling compared to the previous year, signaling that cost structures have not adjusted proportionately to the fall in operational income.

The results were reviewed by the Audit Committee and approved by the Board of Directors on August 14, 2026. The unaudited standalone financial results were filed with the stock exchanges in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.